United States Endoscopes Market Size, Share, and COVID-19 Impact Analysis, By Product (Reusable Endoscopes, Robot- Assisted Endoscopes, Rigid Endoscopes, Flexible Endoscopes, Disposable Endoscopes, and Capsule Endoscopes), By End-use (Outpatient Facilities and Hospitals), and United States Endoscopes Market Insights, Industry Trend, Forecasts to 2035

United States Endoscopes Market Insights Forecasts to 2035

• The US Endoscopes Market Size Was Estimated at USD 6,241.9 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 8.77% from 2025 to 2035
• The US Endoscopes Market Size is Expected to Reach USD 15,741.9 Million by 2035

According to a Research Report Published by Spherical Insights & Consulting, The United States Endoscopes Market Size is anticipated to Reach USD 15,741.9 Million by 2035, Growing at a CAGR of 8.77% from 2025 to 2035. The expansion of the United States endoscopes market is propelled by growing awareness of the growing frequency of chronic ailments, the use of different distribution tactics, and the earlier detection of diseases through less invasive surgical procedures

Market Overview

An endoscope is an exposed tube, either rigid or flexible, with a camera and light source. It is used for visualisation, diagnosis, and sometimes treatment of the inside of hollow organs or body cavities such as the oesophagus, stomach, colon, bladder, joints, or lungs. Endoscopes are commonly passed into an area through small incisions or via the natural openings of the body. Numerous factors have contributed to the endoscopy market's rapid expansion, including rising rates of chronic diseases, the expansion of outpatient service settings, the public's growing acceptance of minimally invasive procedures, advancements in imaging technologies, and the growing demand for disposable endoscopes that adhere to infection control guidelines for patient safety. The increase of chronic diseases requiring minimally invasive diagnostic and therapeutic interventions, and huge, wide-open growth opportunity in the US market, is driven primarily by chronic diseases, including gastrointestinal diseases, colorectal cancer, and neurological diseases. Technological developments in the endoscopic market, including high-definition imaging, AI-assisted diagnostics, and 3D visualisation, are driving broader utilisation by the provider and improving the accuracy of procedure outcomes. Due to various aspects, a growing market in the U.S. is expected, given its advanced healthcare infrastructure, major investment by hospitals and participants in the market to facilitate the take-up of innovative endoscopic products, and favourable reimbursement policies. For instance, EvoEndo raised USD 10.1 million in June 2021 to promote doctors and patients using unsedated transnasal endoscopy.

Report Coverage

This research report categorizes the market for the United States endoscopes market based on various segments and regions and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the United States endoscopes market. Recent market developments and competitive strategies such as expansion, product launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the United States endoscopes market.

Driving Factors

The growth of the United States endoscopes market is boosted by the increasing prevalence of gastrointestinal diseases such as inflammatory bowel disease (IBD), dyspepsia, and constipation, which is an increasing need for endoscopic procedures. Because these diseases are more common, the need for quality diagnostics increases as well. But endoscopes are important for managing these diseases, as they can provide a high level of detail into the GI tract. The endoscope market is growing rapidly as medical facilities are rising at a quicker pace. The governments are also putting resources into improving medical services in impoverished areas. This, in turn, will lead to increased demand for medical devices, including endoscopes. Moreover, with increasing consumer disposable incomes, healthcare expenditures will rise, contributing to adding growth of the market.

Restraining Factors

The United States endoscopes market faces obstacles like businesses competing in price, quality, or innovative technology. Innovation is key for small companies to develop specific technologies to face specific problems or serve niche markets. Unfortunately, the combination of regulatory hurdles and high R&D costs will make it difficult for small companies to compete and grow.

Market Segmentation

The United States endoscopes market share is classified into product and end-use.

• The reusable endoscopes segment held the largest market share in 2024 and is expected to grow at a remarkable CAGR during the forecast period.

The United States endoscopes market is segmented by product into reusable endoscopes, robot- robot-assisted endoscopes, rigid endoscopes, flexible endoscopes, disposable endoscopes, and capsule Endoscopes. Among these, the reusable endoscopes segment held the largest market share in 2024 and is expected to grow at a remarkable CAGR during the forecast period. The segment is driven by the growing incidence of chronic diseases affecting internal body systems, as well as the significant benefits of other technologies, which are expected to support the category's growth. Increased knowledge of the need for early diagnosis in some diseases, such as tumors, respiratory infections, malignancies of the stomach & colon, and inflammatory bowel diseases (IBD), is increasing the need for reusable endoscopes for diagnostic purposes.

• The outpatient facilities segment held the highest revenue share in 2024 and is expected to grow at a significant CAGR during the forecast period.

Based on the end-use, the United States endoscopes market is segmented into outpatient facilities and hospitals. Among these, the outpatient facilities segment held the highest revenue share in 2024 and is expected to grow at a significant CAGR during the forecast period. The segmental growth is propelled because they provide fast & simplistic diagnostic and treatment procedures. Along with the many other advantages they provide, endoscopes are finding their way into outpatient facilities more readily than ever before. One advantage that endoscopes prefer to show off in outpatient facilities is that they can be affordable.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the United States endoscopes market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Stryker Corporation
• Johnson & Johnson
• Boston Scientific Corporation
• Medtronic plc
• Cook group
• Conmed
• Hologic
• Auris Health
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at the United States, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the United States endoscopes market based on the following segments:

United States Endoscopes Market, By Product

• Reusable Endoscopes
• Robot-Assisted Endoscopes
• Rigid Endoscopes
• Flexible Endoscopes
• Disposable Endoscopes
• Capsule Endoscopes

United States Endoscopes Market, By End-use

• Outpatient Facilities
• Hospitals